GLP-1 Medications and HS: What the 2026 Systematic Review Actually Found
A patient-friendly summary of the June 2026 systematic review on GLP-1 receptor agonists (like semaglutide) and hidradenitis suppurativa — 19 studies, 67,568 patients, and what the numbers do and don't prove.